Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
1,631.90
-9.70 (-0.59%)
Aug 5, 2025, 3:29 PM IST
NSE:SUNPHARMA Revenue
Sun Pharmaceutical Industries had revenue of 138.51B INR in the quarter ending June 30, 2025, with 9.47% growth. This brings the company's revenue in the last twelve months to 537.77B, up 9.28% year-over-year. In the fiscal year ending March 31, 2025, Sun Pharmaceutical Industries had annual revenue of 525.78B with 8.42% growth.
Revenue (ttm)
537.77B
Revenue Growth
+9.28%
P/S Ratio
7.32
Revenue / Employee
12.51M
Employees
43,000
Market Cap
3,938.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 525.78B | 40.82B | 8.42% |
Mar 31, 2024 | 484.97B | 46.11B | 10.51% |
Mar 31, 2023 | 438.86B | 52.31B | 13.53% |
Mar 31, 2022 | 386.54B | 51.56B | 15.39% |
Mar 31, 2021 | 334.98B | 6.61B | 2.01% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Divi's Laboratories | 93.60B |
Cipla | 274.80B |
Mankind Pharma | 129.10B |
Apollo Hospitals Enterprise | 217.94B |
Zydus Lifesciences | 232.42B |
Fortis Healthcare | 77.86B |
Aurobindo Pharma | 317.24B |
Alkem Laboratories | 129.65B |
Sun Pharmaceutical Industries News
- 3 days ago - Nifty 50 top losers today, August 1: Sun Pharma, Dr. Reddy’s Laboratories, Adani Enterprises, Cipla and more - Business Upturn
- 4 days ago - Sun Pharma share: Morgan Stanley and HSBC stay positive, see upside up to Rs 1,948 on steady growth and strong India business - Business Upturn
- 4 days ago - Stocks to watch on brokerages, August 1: JSW Energy, Swiggy, TVS, Dabur, Eicher Motors, Maruti Suzuki, and Chola Finance on radar today - Business Upturn
- 4 days ago - Nifty 50 top losers today, July 31: Adani Enterprises, Tata Steel, Sun Pharmaceutical, Dr. Reddy and more - Business Upturn
- 5 days ago - Sun Pharma Q1 Results: Revenue rises 9.5% YoY to Rs 13,851.4 crore, net profit drops 19.6% YoY - Business Upturn
- 5 days ago - Nifty top gainers today, July 30: L&T, Sun Pharma, Tata Consumer Products, NTPC, Maruti Suzuki India and more - Business Upturn
- 11 days ago - Sun Pharma subsidiaries settle US antitrust litigation for $200 million - Business Upturn
- 15 days ago - Sun Pharma reports positive results from Phase 3 trials for ILUMYA - Business Upturn